Bio-Rad Laboratories, Inc. (BIO) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Bio-Rad Laboratories, Inc. (BIO) - Medical Equipment - Deals and Alliances Profile

Bio-Rad Laboratories, Inc. (BIO) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Bio-Rad Laboratories, Inc. (BIO) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
65 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Bio-Rad Laboratories, Inc. (Bio-Rad) undertakes the development and manufacture of specialty chemicals for use in biochemical, pharmaceutical and other life science research applications. The company offers a comprehensive range of reagents, apparatus, laboratory instruments, test systems, informatics systems, test kits and specialized quality controls. It offers these products to hospitals, clinical laboratories, universities, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, and food producers.

Bio-Rad Laboratories, Inc. (BIO) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials an

  
Source:
Document ID
GDME648D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Bio-Rad Laboratories, Inc., Medical Equipment, Deals By Year, 2010 to YTD 201652
Bio-Rad Laboratories, Inc., Medical Equipment Deals By Type, 2010 to YTD 201671
Bio-Rad Laboratories, Inc., Medical Equipment, Deals By Region, 2010 to YTD 201681
Bio-Rad Laboratories, Inc., Medical Equipment, Deals By Market, 2010 to YTD 201691
Bio-Rad Laboratories, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016102
Bio-Rad Laboratories, Inc., Medical Equipment, Deal Details1232
  Asset Purchase121
    Bio-Rad Labs Acquires Flow Cytometer from Propel Labs121
    Bio-Rad Labs Acquires Cell Sorting System From Propel Labs131
  Venture Financing141
    Oxford Impedance Diagnostics Raises USD2.6 Million in Seed Financing141
    QuantaLife Secures US$17.2 Million In Series B Financing151
    QuantaLife Raises US$7.5 Million In Venture Financing161
    QuantaLife Receives Series A Financing From Paladin Capital171
  Partnerships181
    AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies181
    AbD Serotec Enters Into Licensing Agreement With Proteomika191
    Bio-Rad Laboratories Enters into Partnership with Illumina201
    Bio-Rad Labs Extends Agreement with Beckman Coulter Diagnostics211
    Bio-Rad Labs Enters Into Co-Development Agreement With Inpeco221
    Bio-Rad Labs Enters Into Co-Marketing Agreement With Lamprogen For Fluorescent Particles231
    Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits241
    Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX251
    GnuBIO Enters Into Co-Development Agreement With Montreal Heart Institute261
    Bio-Rad Expands Co-Marketing Agreement With Siemens Medical271
    Axis-Shield Signs Option Agreement With Bio-Rad Labs281
    Ariana Pharma Enters Into Collaboration With Bio-Rad Labs, Inserm And Beaujon Hospital292
    Bio-Rad Labs Enters into Licensing agreement with Globavir Biosciences311
    Idaho Technology Enters Into Licensing Agreement With Bio-Rad Labs321
    AbD Serotec Enters Into An Agreement With UCL Business331
  Debt Offering341
    Bio-Rad Labs Completes Public Offering Of Senior Notes Due 2020 For US$425 Million341
  Acquisition351
    Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys For US$70 Million352
    Bio-Rad Labs Acquires QuantaLife For US$162 Million371
    Bio-Rad Labs Acquires Remaining Stake In DiaMed Thailand For US$0.2 Million381
    Bio-Rad Labs Acquires Additional 39% Stake In DiaMed Spain For US$3.4 Million391
    Bio-Rad Labs Acquires Diamed-France401
    Bio-Rad Labs Acquires Additional Stake In Diamed411
    Bio-Rad Labs Completes Acquisition Of Medical Diagnostics Segment From Biotest422
Bio-Rad Laboratories, Inc. - Key Competitors441
Key Employees451
Locations And Subsidiaries464
  Head Office461
  Other Locations &Subsidiaries464
Recent Developments501
Financial Announcements501
Aug 03, 2016: Bio-Rad Reports Second-Quarter 2016 Financial Results501
May 05, 2016: Bio-Rad Reports First-Quarter 2016 Currency-Neutral Revenue Growth of Nearly 4 Percent511
Feb 25, 2016: Bio-Rad Reports Fourth-Quarter and Full-Year 2015 Financial Results522
Nov 03, 2015: Bio-Rad Reports Third-Quarter 2015 Financial Results541
Aug 06, 2015: Bio-Rad Reports Second-Quarter 2015 Financial Results551
May 05, 2015: Bio-Rad Reports First-Quarter 2015 Financial Results561
Feb 26, 2015: Bio-Rad Reports Fourth-Quarter and Full-Year 2014 Financial Results572
Legal and Regulatory591
Dec 21, 2015: 10X Genomics Founders Prevail in Dispute with Bio-Rad591
Product News601
Feb 25, 2016: Bio-Rad Announces CE IVD Marking of Its QX200 Droplet Digital PCR System for Use as an In Vitro Diagnostic601
Apr 13, 2015: Bio-Rad Extends Availability of Its Vitamin D Kit for the BioPlex 2200 System in the U.S.611
Product Approvals621
Feb 25, 2016: Bio-Rad Announces CE IVD Marking of Its QX200 Droplet Digital PCR System for Use as an In Vitro Diagnostic621
Other Significant Developments631
Feb 08, 2016: Bio-Rad Expands its Cell Biology Portfolio with High Performance Flow Cytometer631
Apr 20, 2015: Bio-Rad Grants Beckman Coulter Exclusive Distribution Rights for Access HIV and Hepatitis C Assays641
Appendix651
  Methodology651
  About GlobalData651
  Contact Us651
  Disclaimer651

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Bio-Rad Laboratories, Inc. (BIO) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Bio-Rad-Laboratories-Inc-BIO-Medical-Equipment-Deals-and-Alliances-Profile-2148-1307>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Bio-Rad Laboratories, Inc. (BIO) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Bio-Rad-Laboratories-Inc-BIO-Medical-Equipment-Deals-and-Alliances-Profile-2148-1307>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research